Huang Shunde, Li Xiaohua, Zhu Haotu
ENT & HN Surgery Department, Zhengzhou Central Hospital affiliated with Zhengzhou University, Zhengzhou, Henan, China (mainland).
Department of Hepatopathy, The Sixth People's Hospital of Zhengzhou, Zhengzhou, Henan, China (mainland).
Med Sci Monit. 2016 Nov 13;22:4330-4337. doi: 10.12659/MSM.898110.
BACKGROUND Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer with very high prevalence in southern China. Phosphatase and tensin homolog (PTEN), a tumor suppressor, was reported to be downregulated in NPC patients and correlated with pathological grade and clinical stage of NPC. MATERIAL AND METHODS Luciferase reporter assay, qPCR, and Western blot analysis were used to determine if PTEN is a target of miR-152. The function of miR-152 in cell apoptosis and cell proliferation was examined as well. Tissue samples from NPC patients were also analyzed for PTEN and miR-152 expressions. RESULTS Reporter assay indicated miR-152 targets the 3'UTR of PTEN mRNA to inhibit PTEN expression. Transfection of the NPC-derived cell line with miR-152 mimic confirmed these findings. Overexpression of miRNA-152 inhibits apoptosis induced by Cisplatin in NPC cancer cells in vitro. Moreover, overexpression miR-152 also promotes NPC cancer cell invasion and proliferation. Samples from EBV-negative NPC patients demonstrated the down-regulated level of PTEN may be related with overexpression of miR-152. CONCLUSIONS The miR-152 targets PETN to inhibit cell apoptosis and promote cancer cell proliferation and migration in NPC development.
鼻咽癌(NPC)是一种在中国南方发病率极高的头颈癌。据报道,抑癌基因磷酸酶和张力蛋白同源物(PTEN)在鼻咽癌患者中表达下调,且与鼻咽癌的病理分级和临床分期相关。
采用荧光素酶报告基因检测、qPCR和蛋白质印迹分析来确定PTEN是否为miR-152的靶标。同时也检测了miR-152在细胞凋亡和细胞增殖中的作用。还对鼻咽癌患者的组织样本进行了PTEN和miR-152表达分析。
报告基因检测表明miR-152靶向PTEN mRNA的3'UTR以抑制PTEN表达。用miR-152模拟物转染鼻咽癌来源的细胞系证实了这些发现。miRNA-152的过表达在体外抑制了顺铂诱导的鼻咽癌癌细胞凋亡。此外,miR-152的过表达还促进了鼻咽癌癌细胞的侵袭和增殖。EBV阴性鼻咽癌患者的样本显示PTEN水平下调可能与miR-152的过表达有关。
在鼻咽癌发生发展过程中,miR-152靶向PTEN以抑制细胞凋亡并促进癌细胞增殖和迁移。